Grifols, S.A. logo
Grifols, S.A. GRFS
$ 8.03 0.56%

Quarterly report 2024-Q4
added 05-07-2026

report update icon

Grifols, S.A. Long Term Debt Current 2011-2026 | GRFS

Annual Long Term Debt Current Grifols, S.A.

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
117 M 107 M 102 M 48.6 M 42.6 M 44.4 M - - - - - - - -

All numbers in EUR currency

Indicator range from annual reports

Maximum Minimum Average
117 M 42.6 M 76.9 M

Long Term Debt Current of other stocks in the Biotechnology industry

Issuer Long Term Debt Current Price % 24h Market Cap Country
Arcturus Therapeutics Holdings Arcturus Therapeutics Holdings
ARCT
4.21 M $ 7.15 1.64 % $ 196 M israelIsrael
FSD Pharma FSD Pharma
HUGE
103 K - 5743.5 % $ 69.7 M canadaCanada
MorphoSys AG MorphoSys AG
MOR
3.63 M - 2.43 % $ 254 M germanyGermany
Happiness Biotech Group Limited Happiness Biotech Group Limited
HAPP
102 K - 1.35 % $ 17.8 M chinaChina
AgeX Therapeutics AgeX Therapeutics
AGE
181 K - -10.17 % $ 12.2 K usaUSA
Coherus BioSciences Coherus BioSciences
CHRS
1.83 M $ 1.69 4.66 % $ 198 M usaUSA
I-Mab I-Mab
IMAB
8.06 M - - $ 866 M chinaChina
BioNTech SE BioNTech SE
BNTX
45 M $ 92.82 0.74 % $ 22.4 B germanyGermany
AstraZeneca PLC AstraZeneca PLC
AZN
382 M - - $ 96.9 B britainBritain
Athira Pharma Athira Pharma
ATHA
465 K - - $ 269 M usaUSA
BiondVax Pharmaceuticals Ltd. BiondVax Pharmaceuticals Ltd.
BVXV
773 K - 0.74 % $ 768 M israelIsrael
Compugen Ltd. Compugen Ltd.
CGEN
521 K $ 2.72 -2.86 % $ 254 M israelIsrael
Abcam plc Abcam plc
ABCM
8.5 M - - $ 4.9 B britainBritain
Galera Therapeutics Galera Therapeutics
GRTX
133 K - -32.59 % $ 7.61 M usaUSA
Enlivex Therapeutics Ltd. Enlivex Therapeutics Ltd.
ENLV
235 K $ 0.67 -6.24 % $ 30.6 M israelIsrael
Esperion Therapeutics Esperion Therapeutics
ESPR
2.1 M $ 3.13 -0.16 % $ 651 M usaUSA
Eton Pharmaceuticals Eton Pharmaceuticals
ETON
65 K $ 31.47 -3.44 % $ 847 M usaUSA
Affimed N.V. Affimed N.V.
AFMD
539 K - -34.95 % $ 21.5 M germanyGermany
Forte Biosciences Forte Biosciences
FBRX
416 K $ 21.98 1.81 % $ 285 M usaUSA
Celyad Oncology SA Celyad Oncology SA
CYAD
137 K - - $ 12.5 M belgiumBelgium
Berkeley Lights Berkeley Lights
BLI
3.29 M - -7.31 % $ 87 M usaUSA
Generation Bio Co. Generation Bio Co.
GBIO
13 M - - $ 344 M usaUSA
IMV IMV
IMV
320 K - - $ 13.1 M canadaCanada
Akouos Akouos
AKUS
671 K - 0.23 % $ 488 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
419 K - - $ 7.46 M israelIsrael
Heron Therapeutics Heron Therapeutics
HRTX
3.04 M $ 0.87 1.11 % $ 145 M usaUSA
Freeline Therapeutics Holdings plc Freeline Therapeutics Holdings plc
FRLN
2.66 M - - $ 384 M britainBritain
Gracell Biotechnologies Gracell Biotechnologies
GRCL
17.5 M - - $ 3.37 B chinaChina
Anika Therapeutics Anika Therapeutics
ANIK
2.05 M $ 14.63 -1.68 % $ 210 M usaUSA
Advaxis Advaxis
ADXS
166 K - -9.65 % $ 45.9 M usaUSA
InflaRx N.V. InflaRx N.V.
IFRX
257 K $ 2.76 5.75 % $ 186 M germanyGermany
Aeterna Zentaris Aeterna Zentaris
AEZS
215 K - 5.93 % $ 314 M canadaCanada
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
625 K - - $ 1.01 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
3.47 M - - $ 867 M germanyGermany
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.27 M - - $ 26.5 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
554 K - 1.93 % $ 17.4 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
56 K $ 3.49 2.65 % $ 5.75 M israelIsrael
Aptose Biosciences Aptose Biosciences
APTO
193 K - -45.71 % $ 1.2 M canadaCanada
Aptinyx Aptinyx
APTX
337 K - -39.0 % $ 4.57 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
1.4 M - -0.23 % $ 916 M usaUSA